Vascular Pharmaceuticals, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on Vascular Pharmaceuticals, Inc.

Pink Sheet

J&J Taking The Long View With Its Therapeutic Franchises

 
• By Lisa LaMotta

Johnson & Johnson believes that its success as the most productive pharmaceutical company in the industry is due largely to its life cycle management approach. The company has launched 11 new produc

In Vivo

Biopharma Dealmaking Quarterly Statistics, Q3 2012

Financings During the third quarter of 2012, biopharma financings jumped to just over $3 billion, a 13% increase over the Q2 total. Heading the list was small-molecule cancer therapeutics developer

Scrip

Recent Financings Of Private Companies, October 2012

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS CardioDx Inc. CardioDx sells $58mm of Series CC-1 and Series CC-2 preferred shares CardioDx Inc. (cardiovascular diagnostics) has raised $58mm through the sale of Series C

Scrip

Start-Up Execs On The Move, October 2012

 
• By Regina Paleski

Start-Up Execs Altura Medical Inc. G. Ray Martin, PhD To:Pres. & CEO (August) From:Pres. & CEO, NovoStent Corp. Tel:949-273-5050 Celyad SA Alexander Milstein, MD To:VP, Clinincal Dev. (August)